Etiology and management of idiopathic orbital inflammation
Authors:
- Peter A.D. RubinPRPeter A.D. Rubin
- C. Stephen FosterCFC. Stephen Foster
- 1 December 2004
- journal article
- editorial
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 138 (6) , 1041-1043
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Treatment of recalcitrant idiopathic orbital inflammation (chronic orbital myositis) with infliximabAmerican Journal of Ophthalmology, 2004
- Survey of 1264 patients with orbital tumors and simulating lesionsOphthalmology, 2004
- Robust induction of PGHS-2 by IL-1 in orbital fibroblasts results from low levels of IL-1 receptor antagonist expressionAmerican Journal of Physiology-Cell Physiology, 2003
- Idiopathic Orbital InflammationArchives of Ophthalmology (1950), 2003
- Anti–tumor necrosis factor-alpha therapy with infliximab as an alternative to corticosteroids in the treatment of human leukocyte antigen b27–associated acute anterior uveitisOphthalmology, 2002
- Multiple bilateral eyelid molluscum contagiosum lesions associated with TNFα-antibody and methotrexate therapyAmerican Journal of Ophthalmology, 2002
- Binding and Functional Comparisons of Two Types of Tumor Necrosis Factor AntagonistsThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Development of anti-TNF therapy for rheumatoid arthritisNature Reviews Immunology, 2002
- Upregulation of DAF (CD55) on orbital fibroblasts by cytokines. Differential effects of TNF-ß and TNF-aCurrent Eye Research, 2001
- Orbital involvement in multifocal fibrosclerosis.British Journal of Ophthalmology, 1995